Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

Earnings

Articles You May Like

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Party City to close all of its stores, report says
Celestica (CLS) and AMC Networks (AMCX): 12/20/24 Bull & Bear
Why the Dow is in such a historic funk and how concerned you should be
Starbucks baristas strike in three U.S. cities during pre-Christmas rush